Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure

Han, 2015, Epidemiology of prostate cancer in South Korea, Prostate Int, 3, 99, 10.1016/j.prnil.2015.06.003 Lee, 2019, Trends in prostate cancer prevalence and radical prostatectomy rate according to age structural changes in South Korea between 2005 and 2015, Yonsei Med J, 60, 257, 10.3349/ymj.2019.60.3.257 Jeong, 2021, Impact of the evolving United States Preventative Services Task Force policy statements on incidence and distribution of prostate cancer over 15 years in a statewide cancer registry, Prostate Int, 9, 12, 10.1016/j.prnil.2020.06.002 Barbosa, 2019, Revisiting prostate cancer recurrence with PSMA PET: Atlas of typical and atypical patterns of spread, Radiographics, 39, 186, 10.1148/rg.2019180079 Choi, 2020, Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer, J Cancer Res Clin Oncol, 146, 537, 10.1007/s00432-019-03085-w Kwee, 2012, Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging, Ann Nucl Med, 26, 501, 10.1007/s12149-012-0601-8 Moghul, 2019, Detection rates of recurrent prostate cancer: 68 Gallium (Ga)-labelled prostate-specific membrane antigen versus choline PET/CT scans. A systematic review, Ther Adv Urol, 11, 1, 10.1177/1756287218815793 Niziers, 2020, “Real-world” evaluation of 18F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy, Urol Oncol Semin Orig Investig, 38, 2.e1 Zattoni, 2020, 10-year clinical experience with 18F-choline PET/CT: An Italian multicenter retrospective assessment of 3343 patients, Clin Nucl Med, 45, 594, 10.1097/RLU.0000000000003125 Kim, 2022, Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy, Prostate Int, 10, 135, 10.1016/j.prnil.2022.05.001 Ramírez de Molina, 2002, Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers, Biochem Biophys Res Commun, 296, 580, 10.1016/S0006-291X(02)00920-8 Gillebert, 2018, 18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study, PLoS One, 13, 1, 10.1371/journal.pone.0191487 Mortensen, 2019, 18F-Fluoromethylcholine-positron emission tomography/computed tomography for diagnosing bone and lymph node metastases in patients with intermediate- or high-risk prostate cancer, Prostate Int, 7, 119, 10.1016/j.prnil.2019.01.002 Naik, 2016, Posttreatment prostate-specific antigen 6 months after radiation with androgen deprivation therapy predicts for distant metastasis–free survival and prostate cancer–specific mortality, Int J Radiat Oncol Biol Phys, 96, 617, 10.1016/j.ijrobp.2016.07.009 Ploussard, 2021, Management of persistently elevated prostate-specific antigen after radical prostatectomy: a systematic review of the literature, Eur Urol Oncol, 4, 150, 10.1016/j.euo.2021.01.001 Bolla, 2017, 49 Evangelista, 2013, Choline PET or PET/CT and biochemical relapse of prostate cancer: A systematic review and meta-analysis, Clin Nucl Med, 38, 305, 10.1097/RLU.0b013e3182867f3c Choueiri, 2008, A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy, J Urol, 179, 906 Tam, 2017, Clinical PET imaging in prostate cancer—Erratum, Radiographics, 37 Krause, 2008, The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer, Eur J Nucl Med Mol Imag, 35, 18, 10.1007/s00259-007-0581-4 Giovacchini, 2010, Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy, Eur J Nucl Med Mol Imag, 37, 301, 10.1007/s00259-009-1253-3 Meijer, 2021, Biochemical persistence of prostate-specific antigen after robot-assisted laparoscopic radical prostatectomy: tumor localizations using PSMA PET/CT imaging, J Nucl Med, 62, 961, 10.2967/jnumed.120.252528 Takesh, 2020, Detection rate of 18F-fluorethylcholine-PET/CT in relation to PSA Value in PCA patients referred with biochemical relapse, Contrast Media Mol Imaging, 2020, 10.1155/2020/4320178 Morigi, 2015, Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy, J Nucl Med, 56, 1185, 10.2967/jnumed.115.160382 Wang, 2021, The diagnostic role of 18F-choline, 18F-fluciclovine and 18F-PSMA PET/CT in the detection of prostate cancer with biochemical recurrence: a meta-analysis, Front Oncol, 11 Annunziata, 2020, Diagnostic performance of pet imaging using different radiopharmaceuticals in prostate cancer according to published meta-analyses, Cancers (Basel), 12, 1, 10.3390/cancers12082153 Hegemann, 2020, Outcome after 68ga-psma-11 versus choline pet-based salvage radiotherapy in patients with biochemical recurrence of prostate cancer: A matched-pair analysis, Cancers (Basel), 12, 1 Kim, 2022, Diagnostic accuracy of F-18-Fluorocholine PET/CT and multiparametric MRI for prostate cancer, Prostate Int, 10, 152, 10.1016/j.prnil.2022.04.003 López Rodríguez, 2020, Usefulness of 18F-choline positron emission tomography-computed tomography in the therapeutic management of patients with biochemical recurrence of prostate adenocarcinoma treated with brachytherapy, Actas Urológicas Españolas (English Ed, 44, 437 Albano, 2019, 18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer, Endocrine, 63, 531, 10.1007/s12020-018-01832-6